Gifu, Japan

Satoshi Nohara

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: National Center for Global Health and Medicine. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoshi Nohara. Retrieved from https://idiyas.com/inventor/satoshi-nohara-0tmc5su5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Satoshi Nohara: Innovator in Nuclear Translocation Peptides

Introduction

Satoshi Nohara is a prominent inventor based in Gifu, Japan. He is known for his significant contributions to the field of molecular biology, particularly in the development of peptides that enhance cellular transport mechanisms.

Latest Patents

Nohara holds a patent for a novel nuclear translocation peptide. This invention provides a peptide comprising amino acid sequences R I, F I, and R I G C, which contains 25 or fewer amino acid residues. The peptide is capable of transporting functional molecules into a cell and into the nucleus more efficiently than previous peptide transporters.

Career Highlights

Satoshi Nohara is affiliated with the National Center for Global Health and Medicine, where he conducts research aimed at improving health outcomes through innovative molecular solutions. His work has garnered attention for its potential applications in therapeutic contexts.

Collaborations

Nohara has collaborated with notable colleagues, including Yukihito Ishizaka and Masakatsu Hasegawa. These partnerships have contributed to the advancement of research in the field of peptide technology.

Conclusion

Satoshi Nohara's work in developing nuclear translocation peptides represents a significant advancement in molecular biology. His innovative approach has the potential to enhance the delivery of therapeutic agents, paving the way for future breakthroughs in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…